OliX Pharmaceuticals, Inc 226950.KQ Stock
14640 KRW
{{ price }}
-3.257979%
{{change_pct}}%
COUNTRY
South Korea
Exchange
KOSDAQ
Market Cap
95.25B KRW
LOW - HIGH [24H]
14400
-
14900 KRW
VOLUME [24H]
22.82K KRW
{{ volume }}
P/E Ratio
0
Earnings per share
0 KRW
OliX Pharmaceuticals, Inc Price Chart
OliX Pharmaceuticals, Inc 226950.KQ Financial and Trading Overview
| OliX Pharmaceuticals, Inc stock price | 14640 KRW |
| Previous Close | 18900 KRW |
| Open | 19200 KRW |
| Bid | 18300 KRW x 0 |
| Ask | 18670 KRW x 0 |
| Day's Range | 18140 - 19200 KRW |
| 52 Week Range | 16750 - 29250 KRW |
| Volume | 94.13K KRW |
| Avg. Volume | 74.81K KRW |
| Market Cap | 119.06B KRW |
| Beta (5Y Monthly) | 0.990316 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
226950.KQ Valuation Measures
| Enterprise Value | 252.88B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 12.522703 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 26.598 |
| Enterprise Value/EBITDA | -10.553 |
Trading Information
OliX Pharmaceuticals, Inc Stock Price History
| Beta (5Y Monthly) | 0.990316 |
| 52-Week Change | -31.39% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 29250 KRW |
| 52 Week Low | 16750 KRW |
| 50-Day Moving Average | 20907.6 KRW |
| 200-Day Moving Average | 21182.4 KRW |
226950.KQ Share Statistics
| Avg. Volume (3 month) | 74.81K KRW |
| Avg. Daily Volume (10-Days) | 48.48K KRW |
| Shares Outstanding | 6.51M |
| Float | 9.6M |
| Short Ratio | N/A |
| % Held by Insiders | 29.92% |
| % Held by Institutions | 4.72% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -271.61% |
| Gross Margin | 97.89% |
| EBITDA Margin | -252.046% |
Management Effectiveness
| Return on Assets (ttm) | -16.75% |
| Return on Equity (ttm) | -81.88% |
Income Statement
| Revenue (ttm) | 9.51B KRW |
| Revenue Per Share (ttm) | 693.81 KRW |
| Quarterly Revenue Growth (yoy) | 452.50% |
| Gross Profit (ttm) | 3.5B KRW |
| EBITDA | -23963150336 KRW |
| Net Income Avi to Common (ttm) | -31375216640 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 82.1B KRW |
| Total Cash Per Share (mrq) | 5991.48 KRW |
| Total Debt (mrq) | 41.16B KRW |
| Total Debt/Equity (mrq) | 74.02 KRW |
| Current Ratio (mrq) | 1.966 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -22898147328 KRW |
| Levered Free Cash Flow (ttm) | -1692690048 KRW |
Profile of OliX Pharmaceuticals, Inc
| Country | South Korea |
| State | N/A |
| City | Suwon-si |
| Address | Ace Gwanggyo Tower1 |
| ZIP | 16226 |
| Phone | 82 3 1779 8400 |
| Website | https://www.olixpharma.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 69 |
OliX Pharmaceuticals, Inc. focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases. The company's products pipeline includes OLX101A for skin scar; OLX201A for idiopathic pulmonary fibrosis; OLX301 for age-related macular degeneration; and OLX301D for subretinal fibrosis. The company has a collaboration agreement with Théa to develop SiRNA therapeutics for ophthalmic diseases; and a research collaboration with PCI Biotech Holding ASA. OliX Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Suwon, South Korea.
Q&A For OliX Pharmaceuticals, Inc Stock
What is a current 226950.KQ stock price?
OliX Pharmaceuticals, Inc 226950.KQ stock price today per share is 14640 KRW.
How to purchase OliX Pharmaceuticals, Inc stock?
You can buy 226950.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for OliX Pharmaceuticals, Inc?
The stock symbol or ticker of OliX Pharmaceuticals, Inc is 226950.KQ.
How many shares does OliX Pharmaceuticals, Inc have in circulation?
The max supply of OliX Pharmaceuticals, Inc shares is 6.51M.
What is OliX Pharmaceuticals, Inc Price to Earnings Ratio (PE Ratio)?
OliX Pharmaceuticals, Inc PE Ratio is now.
What was OliX Pharmaceuticals, Inc earnings per share over the trailing 12 months (TTM)?
OliX Pharmaceuticals, Inc EPS is 0 KRW over the trailing 12 months.
OliX Pharmaceuticals, Inc 226950.KQ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Kosdaq MID300 Index KQ300 | 720.6 KRW 0.54 USD |
-1.89
|
70.17K KRW 53 USD | 716.77 KRW 0.54 USD | 724.74 KRW 0.55 USD | — - | 70.17K KRW 53 USD |
| Kosdaq Other Services Index KQ16 | 3522.26 KRW 2.66 USD |
-2.5
|
15.31K KRW 12 USD | 3508.16 KRW 2.65 USD | 3576.45 KRW 2.7 USD | — - | 15.31K KRW 12 USD |
- {{ link.label }} {{link}}